Yahoo Web Search

Search results

1. • 

     Is AbbVie (ABBV) a High Growth Potential Stock?

     Insider Monkey via Yahoo Finance· 2 years ago

     Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be...

2. • 

     Here’s Why Baron Health Care Fund Trimmed AbbVie (ABBV)

     Insider Monkey via Yahoo Finance· 1 year ago

     Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter...

3. • 

     AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study

     Zacks via Yahoo Finance· 7 months ago

     AbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...

4. • 

     AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs

     Zacks via Yahoo Finance· 1 year ago

     AbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...

5. • 

     10 Best Safe Dividend Stocks for Retirement Portfolios

     Insider Monkey via Yahoo Finance· 2 years ago

     In this article, we discuss the 10 best safe dividend stocks for retirement portfolios. If you want...

6. • 

     AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio

     Zacks via Yahoo Finance· 2 months ago

     AbbVie ABBV announced a definitive agreement to acquire Landos Biopharma LABP, which makes novel,...

7. • 

     AbbVie's (ABBV) Skyrizi Meets Ulcerative Colitis Study Goals

     Zacks via Yahoo Finance· 11 months ago

     AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical...

8. • 

     AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners

     Benzinga via Yahoo Finance· 1 year ago

     CytomX Therapeutics Inc (NASDAQ: CTMX) will weigh its options for CX-2029, a CD71-directed...

9. • UPDATE 2-JNJ, AbbVie plan to pull US accelerated approvals for some blood cancer treatments

     Reuters via Yahoo Finance· 1 year ago

     AbbVie Inc and partner Johnson & Johnson intend to voluntarily withdraw the accelerated approvals of their Imbruvica drug in the U.S. for patients with certain types of blood cancer, the companies ...

10. • 

      13 Best Defensive Stocks To Buy Now

      Insider Monkey via Yahoo Finance· 9 months ago

      In this article, we will take a look at the 13 best defensive stocks to buy now. To see more such companies, go directly to 5 Best Defensive Stocks To...